KS 1290 Part 4 2007 Chemicals used for treatment of water intended for human consumption. Part 4: Calcium Hypochlorite – specification (9 pages, in English).
Distribution date: 15 February 2007
Products Covered: Calcium Hypochlorite (ICS: 2810; 71.06.50)
Regulation Type: Regular notification
KS 1290 Part 4 2007 Chemicals used for treatment of water intended for human consumption. Part 4: Calcium Hypochlorite – specification (9 pages, in English).
Distribution date: 15 February 2007
Products Covered: Calcium Hypochlorite (ICS: 2810; 71.06.50)
Regulation Type: Regular notification
KS 2094: 2006 Accident Action Pack for Personal and Public Service Vehicles (PSV) (10 Pages, in English).
Distribution date: 19 January 2007
Products Covered: Accident Action Pack (ICS: 13.200)
Regulation Type: Regular notification
KS 2094: 2006 Accident Action Pack for Personal and Public Service Vehicles (PSV) (10 Pages, in English).
Distribution date: 19 January 2007
Products Covered: Accident Action Pack (ICS: 13.200)
Regulation Type: Regular notification
Notice: Food Labeling: Health Claims; Calcium and Osteoporosis and Calcium, Vitamin D, and Osteoporosis; Proposed rule (Available in English; 23 pages).
Distribution date: 16 January 2007
The US Food and Drug Administration is proposing to amend the calcium and osteoporosis health claim regulation (21 CFR 101.72) to: (1) Include vitamin D so that, claims can be made for calcium and vitamin D and osteoporosis; (2) eliminate the requirement that the claim list sex, race, and age as specific risk factors for the development of osteoporosis; (3) eliminate the requirement that the claim does not state or imply that the risk of osteoporosis is equally applicable to the general United States population, and that the claim identify the populations at particular risk for the development of osteoporosis; (4) eliminate the requirement that the claim identify the mechanism by which calcium reduces the risk of osteoporosis and instead make it optional; and (5) eliminate the conditional requirement that the claim include a statement that reflects the limit of the benefits derived from dietary calcium intake. This proposal responds to a health claim petition submitted by the Beverage Institute for Health and Wellness, the Coca-Cola Company.
Products Covered: Not applicable
Regulation Type: Regular notification
Notice: Food Labeling: Health Claims; Calcium and Osteoporosis and Calcium, Vitamin D, and Osteoporosis; Proposed rule (Available in English; 23 pages).
Distribution date: 16 January 2007
The US Food and Drug Administration is proposing to amend the calcium and osteoporosis health claim regulation (21 CFR 101.72) to: (1) Include vitamin D so that, claims can be made for calcium and vitamin D and osteoporosis; (2) eliminate the requirement that the claim list sex, race, and age as specific risk factors for the development of osteoporosis; (3) eliminate the requirement that the claim does not state or imply that the risk of osteoporosis is equally applicable to the general United States population, and that the claim identify the populations at particular risk for the development of osteoporosis; (4) eliminate the requirement that the claim identify the mechanism by which calcium reduces the risk of osteoporosis and instead make it optional; and (5) eliminate the conditional requirement that the claim include a statement that reflects the limit of the benefits derived from dietary calcium intake. This proposal responds to a health claim petition submitted by the Beverage Institute for Health and Wellness, the Coca-Cola Company.
Products Covered: Not applicable
Regulation Type: Regular notification
Draft Ministerial Act Number 330, 13 December 2006 (Portaria nº 330, de 13 de dezembro de 2006) (3 pages, in Portuguese).
Distribution date: 10 January 2007
Products Covered: Cosmetics (HS: 3300)
Regulation Type: Regular notification
Draft Ministerial Act Number 330, 13 December 2006 (Portaria nº 330, de 13 de dezembro de 2006) (3 pages, in Portuguese).
Distribution date: 10 January 2007
Products Covered: Cosmetics (HS: 3300)
Regulation Type: Regular notification
Food Labeling: Health Claims; Calcium and Osteoporosis, and Calcium, Vitamin D, and Osteoporosis (23 pages, in English).
Distribution date: 10 January 2007
The Food and Drug Administration (FDA) is proposing to amend the regulation authorizing a health claim on the relationship between calcium and a reduced risk of osteoporosis to: Include vitamin D so that, in addition to claims for calcium and osteoporosis, additional claims can be made for calcium and vitamin D and osteoporosis.
Products Covered: Food Labeling (HS: Chapter 2936; ICS: 67.040)
Regulation Type: Regular notification
Food Labeling: Health Claims; Calcium and Osteoporosis, and Calcium, Vitamin D, and Osteoporosis (23 pages, in English).
Distribution date: 10 January 2007
The Food and Drug Administration (FDA) is proposing to amend the regulation authorizing a health claim on the relationship between calcium and a reduced risk of osteoporosis to: Include vitamin D so that, in addition to claims for calcium and osteoporosis, additional claims can be made for calcium and vitamin D and osteoporosis.
Products Covered: Food Labeling (HS: Chapter 2936; ICS: 67.040)
Regulation Type: Regular notification
Submit your email ID to receive notifications about upcoming courses and events
